XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS’ EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of Share Repurchase Authorized by Board of Directors The Board of Directors of Lazard authorized the repurchase of Lazard, Inc. common stock (“common stock”) as set forth in the table below as of September 30, 2024:
DateRepurchase
Authorization
Expiration
February 2022$300,000 December 31, 2024
July 2022$500,000 December 31, 2024
July 2024$200,000 December 31, 2026
Schedule of Shares Repurchased Under the Share Repurchase Program Purchases with respect to such program are set forth in the table below:
Nine Months Ended September 30:Number of
Shares
Purchased
Average
Price Per
Share
20232,782,662$36.67 
20241,123,413$39.10 
Schedule of Accumulated Other Comprehensive Income (Loss), Net of Tax The tables below reflect the balances of each component of AOCI at September 30, 2024 and 2023 and activity during the three month and nine month periods then ended:
Three Months Ended September 30, 2024
Currency
Translation
Adjustments
Employee
Benefit
Plans
Total
AOCI
Amount
Attributable to
Noncontrolling
Interests
Total
Lazard, Inc.
AOCI
Balance - July 1, 2024$(144,825)$(161,467)$(306,292)$$(306,293)
Activity:
Other comprehensive income (loss) before reclassifications41,627 (9,033)32,594 33 32,561 
Adjustments for items reclassified to earnings, net of tax– 1,888 1,888 – 1,888 
Net other comprehensive income (loss)41,627 (7,145)34,482 33 34,449 
Balance, September 30, 2024$(103,198)$(168,612)$(271,810)$34 $(271,844)
Nine Months Ended September 30, 2024
Currency
Translation
Adjustments
Employee
Benefit
Plans
Total
AOCI
Amount
Attributable to
Noncontrolling
Interests
Total
Lazard, Inc.
AOCI
Balance - January 1, 2024$(123,991)$(165,958)$(289,949)$$(289,950)
Activity:
Other comprehensive income (loss) before reclassifications20,793 (7,429)13,364 33 13,331 
Adjustments for items reclassified to earnings, net of tax– 4,775 4,775 – 4,775 
Net other comprehensive income (loss)20,793 (2,654)18,139 33 18,106 
Balance, September 30, 2024$(103,198)$(168,612)$(271,810)$34 $(271,844)
Three Months Ended September 30, 2023
Currency
Translation
Adjustments
Employee
Benefit
Plans
Total
AOCI
Amount
Attributable to
Noncontrolling
Interests
Total
Lazard, Inc.
AOCI
Balance - July 1, 2023$(139,907)$(141,980)$(281,887)$(1)$(281,886)
Activity:
Other comprehensive income (loss) before reclassifications(19,935)5,054 (14,881)(14,882)
Adjustments for items reclassified to earnings, net of tax2,129 1,580 3,709 – 3,709 
Net other comprehensive income (loss)(17,806)6,634 (11,172)(11,173)
Balance, September 30, 2023$(157,713)$(135,346)$(293,059)$– $(293,059)
Nine Months Ended September 30, 2023
Currency
Translation
Adjustments
Employee
Benefit
Plans
Total
AOCI
Amount
Attributable to
Noncontrolling
Interests
Total
Lazard, Inc.
AOCI
Balance - January 1, 2023$(156,924)$(138,930)$(295,854)$– $(295,854)
Activity:
Other comprehensive loss before reclassifications(2,946)(332)(3,278)– (3,278)
Adjustments for items reclassified to earnings, net of tax2,157 3,916 6,073 – 6,073 
Net other comprehensive income (loss)(789)3,584 2,795 – 2,795 
Balance, September 30, 2023$(157,713)$(135,346)$(293,059)$– $(293,059)
Schedule of Adjustments for Items Reclassified From AOCI
The table below reflects adjustments for items reclassified out of AOCI, by component, for the three month and nine month periods ended September 30, 2024 and 2023:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Currency translation losses (a)$– $2,129 $– $2,157 
Employee benefit plans:
Amortization relating to employee benefit plans (b)2,433 1,954 6,230 5,051 
Less - related income taxes545 374 1,455 1,135 
1,888 1,580 4,775 3,916 
Total reclassifications, net of tax$1,888 $3,709 $4,775 $6,073 
__________________________

(a)Represents currency translation losses reclassified from AOCI associated with closing of certain of our offices. Such amounts are included in “revenue–other” on the condensed consolidated statements of operations.
(b)Included in the computation of net periodic benefit cost (see Note 14). Such amounts are included in “operating expenses–other” on the condensed consolidated statements of operations.